Rashmi Kanagal‐Shamanna

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979

Top 19%

1.0DataRank

Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Papers

Driven by 43 papers — median percentile 40. Top paper: “Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma”.

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Journal of Clinical Oncology(2021)10.1200/jco.21.01797

N/A

2.5DataRank · unranked

83 citations

Shuangtao Zhao, Hun Ju Lee, Holly A. Hill, Chi Young Ok, Rashmi Kanagal‐Shamanna +22 more

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Nature Medicine(2022)10.1038/s41591-022-01696-4

N/A

2.2DataRank · unranked

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00638-0

N/A

1.5DataRank · unranked

56 citations

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01476-8

N/A

1.3DataRank · unranked

51 citations

Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo +22 more

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979

Top 19%

1.0DataRank

Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Blood Advances(2020)10.1182/bloodadvances.2019001101

N/A

0.735DataRank · unranked

133 citations

Rashmi Kanagal‐Shamanna, Christopher B. Benton, Caleb A. Class, Kelly S. Chien, Koji Sasaki +17 more

Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes

Cancer(2021)10.1002/cncr.33745

N/A

0.524DataRank · unranked

32 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Faezeh Darbaniyan, Elias Jabbour, Carlos E. Bueso‐Ramos +13 more

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma

Blood Cancer Journal(2023)10.1038/s41408-023-00927-2

N/A

0.425DataRank · unranked

16 citations

Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly A. Hill, Chi Young Ok +8 more

Natural killer cells’ functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes

Nature Communications(2025)10.1038/s41467-025-58662-0

N/A

0.321DataRank · unranked

7 citations

Irene Gañán‐Gómez, Bijender Kumar, Natthakan Thongon, Feiyang Ma, Kelly S. Chien +35 more

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

Haematologica(2025)10.3324/haematol.2024.286559

N/A

0.165DataRank · unranked

2 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado +19 more

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.22.529457

N/A

0.104DataRank · unranked

1 citations

Feiyang Ma, Pamela Lockyer, Natalia Baran, Jintan Liu, C. Ellen Jackson +27 more

Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferative disease in mice via altered Runx1 splicing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.05.429385

N/A

0DataRank · unranked

1 citations

Prerna Malaney, Xiaorui Zhang, Shelley M. Herbrich, Lauren E Chan, Huaxian Ma +8 more

Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation community

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.13.448171

Top 100%

0DataRank

Top 100%0 citations

Arpad Danos, Susanna Kiwala, Joshua F. McMichael, Adam Coffman, Erica K. Barnell +47 more

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine(2022)10.1016/j.gim.2022.01.001

N/A

0DataRank · unranked

245 citations

Malachi Griffith, Arpad Danos, Beth A. Pitel, Subha Madhavan, Xue‐Lu Liu +42 more

Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms

Blood(2022)10.1182/blood.2021014956

N/A

0DataRank · unranked

140 citations

Veronica Guerra, James A. Kennedy, Yuanqing Yan, Joanne I. Hsu, Feng Wang +20 more

Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing

NAR Cancer(2022)10.1093/narcan/zcac039

N/A

0DataRank · unranked

13 citations

Prerna Malaney, Xiaorui Zhang, Shelley M. Herbrich, Lauren E Chan, Oscar Benitez +10 more

TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis

American Journal of Hematology(2022)10.1002/ajh.26595

N/A

0DataRank · unranked

14 citations

Raamis Khwaja, Rashmi Kanagal‐Shamanna, Guilin Tang, Jan A. Burger, Philip A. Thompson +10 more

Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy

Annual Review of Pathology Mechanisms of Disease(2023)10.1146/annurev-pathmechdis-051222-122724

N/A

0DataRank · unranked

36 citations

David B. Beck, Katherine R. Calvo, Rashmi Kanagal‐Shamanna

Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.06.015

N/A

0DataRank · unranked

9 citations

Uri Greenbaum, Oren Pasvolsky, Denái R. Milton, Rashmi Kanagal‐Shamanna, Jeremy Ramdial +15 more

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era

American Journal of Hematology(2023)10.1002/ajh.27037

N/A

0DataRank · unranked

20 citations

Koji Sasaki, Aram Bidikian, Ghayas C. Issa, Tapan M. Kadia, Nitin Jain +11 more

Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features

The American Journal of Surgical Pathology(2023)10.1097/pas.0000000000002068

N/A

0DataRank · unranked

10 citations

Huan Mo, Do H. Kim, Ali Sakhdari, Ken H. Young, Preetesh Jain +8 more

Ibrutinib, Fludarabine, Cyclophosphamide and Obinutuzumab (iFCG) for Firstline Treatment of Patients with CLL with Mutated IGHV and without Del(17p)/ TP53 Mutation: Six-Year Follow-up Analyses

Blood(2023)10.1182/blood-2023-188084

N/A

0DataRank · unranked

1 citations

Philip A. Thompson, Akhil Jain, Jan A. Burger, Alessandra Ferrajoli, Jayastu Senapati +27 more

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Blood(2023)10.1182/blood-2023-181312

N/A

0DataRank · unranked

1 citations

Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair +14 more

Genomic and Transcriptomic Profiles of Blastoid and Pleomorphic Mantle Cell Lymphoma Are Distinct from Classic Histology Mantle Cell Lymphoma

Blood(2023)10.1182/blood-2023-181319

N/A

0DataRank · unranked

0 citations

Holly A. Hill, Chi Young Ok, Alexander Nesmalov, Vitaly Segodin, Dmitry Tabakov +13 more

Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101585

N/A

0DataRank · unranked

14 citations

Natthakan Thongon, Juan José Rodríguez‐Sevilla, Feiyang Ma, Irene Gañán‐Gómez, Hui Yang +16 more

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Nature Communications(2024)10.1038/s41467-024-46424-3

N/A

0DataRank · unranked

10 citations

Irene Gañán‐Gómez, Feiyang Ma, Kelly S. Chien, Mónica Del Rey, Sanam Loghavi +13 more

Landscape and Clinicopathologic Features of RAS Pathway Mutations in Chronic Myelomonocytic Leukemia

Blood(2024)10.1182/blood-2024-208890

N/A

0DataRank · unranked

1 citations

Kelly S. Chien, Sanam Loghavi, Rashmi Kanagal‐Shamanna, Anuya Natu, Mark E. Gurney +22 more

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2020003120

N/A

0DataRank · unranked

182 citations

Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel Franquiz, Rashmi Kanagal‐Shamanna +12 more

A Phase II Trial of Azacitidine with Ipilimumab, Nivolumab, or Ipilimumab and Nivolumab with or without Azacitidine in Relapsed or Refractory Myelodysplastic Syndrome

Blood(2024)10.1182/blood-2024-205186

N/A

0DataRank · unranked

0 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado Valero +15 more

Clonal Origin of Therapy-Related Myeloid Neoplasms after Autologous Stem Cell Transplant

Blood(2024)10.1182/blood-2024-208106

N/A

0DataRank · unranked

0 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +35 more

Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

Nature Genetics(2025)10.1038/s41588-025-02235-w

N/A

0DataRank · unranked

11 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +39 more

Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia

Sensors & Diagnostics(2025)10.1039/d4sd00357h

N/A

0DataRank · unranked

1 citations

Binh Vu, Kristen Brosamer, Sophia Song, Vijay Maranholkar, Zihua Zeng +6 more

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood(2024)10.1182/blood-2024-206042

N/A

0DataRank · unranked

1 citations

Chi Young Ok, Jason R. Westin, Holly A. Hill, Ranjit Nair, Swaminathan P. Iyer +28 more

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001156

N/A

0DataRank · unranked

43 citations

Keyur P. Patel, Maher Albitar, Miguel Franquiz, Rajyalakshmi Luthra, Rashmi Kanagal‐Shamanna +15 more

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

Blood Cancer Journal(2020)10.1038/s41408-020-0329-y

N/A

0DataRank · unranked

36 citations

Hagop M. Kantarjian, Rashmi Kanagal‐Shamanna, Koji Sasaki, Farhad Ravandi, Jörge E. Cortes +15 more

A heavy metal baseline score predicts outcome in acute myeloid leukemia

American Journal of Hematology(2020)10.1002/ajh.25731

N/A

0DataRank · unranked

25 citations

Philippe Télouk, Steven M. Kornblau, Francis Albarède, Peter P. Ruvolo, Rebecca S. Tidwell +7 more

Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3)

American Journal of Hematology(2020)10.1002/ajh.25991

N/A

0DataRank · unranked

6 citations

Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Elias Jabbour, Farhad Ravandi, Tapan M. Kadia +13 more

Only SF3B1 Mutation involving K700E (And Not Other Codons), Independently Predicts Overall Survival in Myelodysplastic Syndromes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.04.283598

N/A

0DataRank · unranked

0 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Elias Jabbour, Carlos E. Bueso‐Ramos, Yue Wei +14 more

Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study

UNC Libraries(2020)10.17615/xb7c-ht96

N/A

0DataRank · unranked

0 citations

Tzankov, Alexander, Zijun Y. Xu‐Monette, Cherie H. Dunphy, Michel Bihl, Pei Lin +13 more

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

Nature Communications(2021)10.1038/s41467-021-22872-z

N/A

0DataRank · unranked

68 citations

Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu +33 more

Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

Leukemia(2021)10.1038/s41375-021-01240-2

N/A

0DataRank · unranked

31 citations

Danielle Hammond, Courtney D. DiNardo, Marina Konopleva, Gautam Borthakur, Nicholas J. Short +15 more

EZH2 expression is associated with inferior overall survival in mantle cell lymphoma

Modern Pathology(2021)10.1038/s41379-021-00885-9

N/A

0DataRank · unranked

13 citations

Ali Sakhdari, Huan Mo, Do H. Kim, Rashmi Kanagal‐Shamanna, Shaoying Li +11 more

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Blood Cancer Journal(2021)10.1038/s41408-021-00446-y

N/A

0DataRank · unranked

10 citations

Guillermo Montalban‐Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour +26 more

Rashmi Kanagal‐Shamanna

Indexed papers

Top data-sharing exemplar

Papers